Skip to main content
Clinical Trials/NCT00213200
NCT00213200
Completed
Phase 3

Systemic Analgesia and Local Anaesthesia for Percutaneous Venous Catheter Placement in Preterm Neonates

The Hospital for Sick Children2 sites in 1 country108 target enrollmentJuly 2003

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Pain
Sponsor
The Hospital for Sick Children
Enrollment
108
Locations
2
Primary Endpoint
- Facial grimacing, as assessed by brow bulge, at the time of the procedure, compared among groups
Status
Completed
Last Updated
19 years ago

Overview

Brief Summary

This study will test which type of pain medication is best for the management of pain in newborn preterm and full-term infants having a deep intravenous cannula inserted. It will compare the effectiveness of intravenous morphine alone, a local anaesthetic cream (amethocaine) alone, and both medications together. It will also determine the safety of both medications.

Registry
clinicaltrials.gov
Start Date
July 2003
End Date
June 2005
Last Updated
19 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • preterm and full-term infants in the NICU requiring a percutaneous central venous catheter
  • ventilatory support in the form of conventional ventilation, Continuous Positive Air Pressure (CPAP) or High Frequency Oscillation(HFO)

Exclusion Criteria

  • receiving muscle relaxants
  • skin disorders causing disruption of stratum corneum

Outcomes

Primary Outcomes

- Facial grimacing, as assessed by brow bulge, at the time of the procedure, compared among groups

Secondary Outcomes

  • heart rate at the time of procedure
  • oxygen saturation at the time of procedure
  • local skin reactions at the time of procedure
  • blood pressure for 24 hours post procedure
  • ventilatory support for 24 hours post procedure

Study Sites (2)

Loading locations...

Similar Trials